HOME >> BIOLOGY >> NEWS
UT Southwestern researchers engineer cells that may hold key to treating inflammatory diseases

DALLAS - August 4, 1999 - Researchers at UT Southwestern Medical Center at Dallas have converted specialized cells that normally trigger an immune response into cells that trigger cell death.

The research, reported in this month's issue of Nature Medicine, involved the molecular engineering of cells in mice - a procedure that could eventually lead to the prevention and treatment of inflammatory diseases such as rheumatoid arthritis.

"What we did was to change the concept entirely. We tried to convert dendritic cells (which signal for an immune response) into cells that deliver death signals instead of activation signals," said Dr. Akira Takashima, the Thomas L. Shields, M.D., Professor in Dermatology.

Dendritic cells are specialized white blood cells that serve an important function within the immune system. Normally they send activation signals to T lymphocytes to begin multiplying and initiate an immune response.

"Sometimes the dendritic cells that can help a person acquire protective immunity are also involved in the induction of harmful immune responses," said Takashima. "There are many diseases, especially inflammatory diseases, where T cells play a pathogenic role."

For example, rheumatoid arthritis is a common inflammatory joint disease believed to be caused by an autoimmune response. Patients' immune systems form antibodies that improperly attack the lining surrounding joints, causing chronic inflammation.

"The next step is to translate our knowledge of dendritic cells and apply this technology into clinical trials for treating the various diseases caused by T cells," Takashima said.

Dr. Hiroyuki Matsue, assistant professor of dermatology at UT Southwestern and primary author of the study, collaborated with Takashima and other researchers from UT Southwestern, including Keiko Matsue, postdoctoral researcher, and Michael Walters, research technician.

National Institutes of Health grants supported the study.


'"/>

Contact: Ione Echeverria
ione.echeverria@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
4-Aug-1999


Page: 1

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
10. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
11. UT Southwestern research halts narcolepsy symptoms

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2020)... ... February 07, 2020 , ... dicentra ... natural health product, nutraceutical and dietary supplement industries, announces 2020 membership with the ... regulatory expertise and research pertaining to probiotics. We are thrilled to join our ...
(Date:2/5/2020)... ... February 04, 2020 , ... ... issued the company a second patent related to proprietary liquid crystal technology for ... another patent from the USPTO issued on December 3, 2019. Together, these patents ...
(Date:1/30/2020)... ... 30, 2020 , ... Accelera Canada , a full-service firm delivering end-to-end ... pleased to announce that the company has opened the doors of its first office ... , “We are so thrilled to now have all our partners and their ...
Breaking Biology News(10 mins):
(Date:2/5/2020)... ... ... Rare Disease Day® , held the last day in February each ... to raise awareness amongst the general public and decision-makers about rare diseases and their ... rare disease series will be shining the light on Rare Disease Day ...
(Date:1/28/2020)... ... January 28, 2020 , ... Lifecycle Biotechnologies announced ... beverage manufactures within North America. Both Lifecycle and Midland have supported this industry ... company to pool their collective resources and provide the industry with support, service, ...
(Date:1/27/2020)... , ... January 27, 2020 , ... ... in neuroscience and cloud and mobile computing, today announced the availability of neuroscience ... an organization to use the latest neuroscience of leadership and change research to ...
(Date:1/24/2020)... ... January 24, 2020 , ... The ... in biotechnology, diagnostics, therapeutics, laboratory and clinical services during the first two decades ... the world. And as Slone Partners celebrates its 20th anniversary this ...
Breaking Biology Technology:
Cached News: